Header cover image

Pakistani (KSE) Pharma Industry Analysis

UpdatedFeb 19, 2026
DataAggregated Company Financials
Companies11
  • 7D-3.3%
  • 3M6.2%
  • 1Y8.3%
  • YTD1.7%

Over the last 7 days, the Pharma industry has dropped 3.3%, driven by declines in GlaxoSmithKline Pakistan and AGP of 7.4% and 12%, respectively. Over the past 12 months, the industry was up 8.3%. As for the next few years, earnings are expected to grow by 14% per annum.

Industry Valuation and Performance

Has the Pakistani Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 19 Feb 2026PK₨533.3bPK₨297.3bPK₨29.2b17.4x18.3x1.8x
Sat, 17 Jan 2026PK₨547.5bPK₨297.3bPK₨29.2b17.3x18.8x1.8x
Mon, 15 Dec 2025PK₨499.8bPK₨297.4bPK₨29.4b15.8x17x1.7x
Wed, 12 Nov 2025PK₨502.1bPK₨297.4bPK₨29.4b16x17.1x1.7x
Fri, 10 Oct 2025PK₨536.2bPK₨286.9bPK₨28.0b22.3x19.2x1.9x
Sun, 07 Sep 2025PK₨522.4bPK₨285.7bPK₨29.0b24.1x18x1.8x
Tue, 05 Aug 2025PK₨497.8bPK₨279.5bPK₨26.2b22.7x19x1.8x
Thu, 03 Jul 2025PK₨477.3bPK₨279.5bPK₨26.2b22.8x18.2x1.7x
Sat, 31 May 2025PK₨449.3bPK₨279.5bPK₨26.2b18.7x17.1x1.6x
Mon, 28 Apr 2025PK₨468.6bPK₨272.9bPK₨23.3b22x20.1x1.7x
Wed, 26 Mar 2025PK₨480.2bPK₨266.0bPK₨20.9b24.7x23x1.8x
Fri, 21 Feb 2025PK₨475.4bPK₨257.1bPK₨19.2b23.9x24.8x1.8x
Sun, 19 Jan 2025PK₨491.4bPK₨257.1bPK₨19.2b23.5x25.7x1.9x
Tue, 17 Dec 2024PK₨490.6bPK₨257.0bPK₨19.0b24.3x25.8x1.9x
Thu, 14 Nov 2024PK₨394.9bPK₨257.0bPK₨19.0b20x20.8x1.5x
Sat, 12 Oct 2024PK₨294.3bPK₨245.0bPK₨15.2b18x19.4x1.2x
Mon, 09 Sep 2024PK₨259.0bPK₨251.2bPK₨12.3b14.9x21x1x
Wed, 07 Aug 2024PK₨241.2bPK₨243.6bPK₨8.3b16.9x29.2x1x
Fri, 05 Jul 2024PK₨255.1bPK₨243.6bPK₨8.3b17x30.8x1x
Sun, 02 Jun 2024PK₨221.2bPK₨238.7bPK₨8.0b16.1x27.5x0.9x
Tue, 30 Apr 2024PK₨194.1bPK₨228.8bPK₨6.6b32.9x29.5x0.8x
Thu, 28 Mar 2024PK₨168.0bPK₨224.1bPK₨6.3b20.8x26.5x0.7x
Sat, 24 Feb 2024PK₨172.7bPK₨221.2bPK₨6.3b21.7x27.5x0.8x
Mon, 22 Jan 2024PK₨161.9bPK₨221.2bPK₨6.3b19.8x25.7x0.7x
Wed, 20 Dec 2023PK₨166.4bPK₨221.2bPK₨6.3b20.8x26.4x0.8x
Fri, 17 Nov 2023PK₨153.0bPK₨218.2bPK₨6.2b20.3x24.7x0.7x
Sun, 15 Oct 2023PK₨137.5bPK₨211.7bPK₨6.6b17.4x20.8x0.6x
Tue, 12 Sep 2023PK₨122.0bPK₨209.3bPK₨8.2b12x14.8x0.6x
Thu, 10 Aug 2023PK₨139.5bPK₨205.6bPK₨8.7b13x16x0.7x
Sat, 08 Jul 2023PK₨138.9bPK₨205.6bPK₨8.7b13.1x15.9x0.7x
Mon, 05 Jun 2023PK₨132.4bPK₨205.2bPK₨9.3b13.5x14.2x0.6x
Wed, 03 May 2023PK₨141.3bPK₨194.5bPK₨13.5b10.1x10.5x0.7x
Fri, 31 Mar 2023PK₨141.7bPK₨191.5bPK₨15.1b9x9.4x0.7x
Sun, 26 Feb 2023PK₨141.3bPK₨189.4bPK₨15.2b9.2x9.3x0.7x
Price to Earnings Ratio

9.3x


Total Market Cap: PK₨141.3bTotal Earnings: PK₨15.2bTotal Revenue: PK₨189.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Pakistani Pharma Industry Price to Earnings3Y Average 20.6x202420252026
Current Industry PE
  • Investors are pessimistic on the Pakistani Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 18.3x which is lower than its 3-year average PE of 20.6x.
  • The 3-year average PS ratio of 1.2x is lower than the industry's current PS ratio of 1.8x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 24% per year over the last three years.
  • Revenues for these companies have grown 16% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Pakistani Healthcare industry?

PK Market-2.47%
Healthcare-3.57%
Pharma-3.30%
Pharma-3.30%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
OTSU Otsuka PakistanPK₨384.660.6%
+PK₨29.2m
86.2%PE17.4x

Latest News